Fluorescent exendin-4 derivatives for pancreatic β-cell analysis. 2014

Susan M Clardy, and Edmund J Keliher, and James F Mohan, and Matt Sebas, and Christophe Benoist, and Diane Mathis, and Ralph Weissleder
Center for Systems Biology, Massachusetts General Hospital , 185 Cambridge Street, CPZN 5206, Boston, Massachusetts 02114, United States.

The ability to reliably identify pancreatic β-cells would have far reaching implications for a greater understanding of β-cell biology, measurement of β-cell mass in diabetes, islet transplantation, and drug development. The glucagon-like peptide-1 receptor (GLP1R) is highly expressed on the surface of insulin producing pancreatic β-cells. Using systematic modifications of the GLP1R ligand, exendin-4, we screened over 25 compounds and identified a palette of fluorescent exendin-4 with high GLP1R binding affinity. We show considerable differences in affinity, as well as utility of the top candidates for flow cytometry and microscopy of β-cells. Some of the developed compounds should be particularly useful for basic and translational β-cell research.

UI MeSH Term Description Entries
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005453 Fluorescence The property of emitting radiation while being irradiated. The radiation emitted is usually of longer wavelength than that incident or absorbed, e.g., a substance can be irradiated with invisible radiation and emit visible light. X-ray fluorescence is used in diagnosis.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000067757 Glucagon-Like Peptide-1 Receptor A receptor for GLUCAGON-LIKE PEPTIDE 1 (GLP-1) expressed primarily on the surface of beta and ductal exocrine cells of the pancreas, as well as cells of other tissues. GLP-1 acts through GLP-1R to potentiate signaling in pancreatic cells in response to glucose-stimulated insulin secretion (GSIS). GLP-1 Receptor,GLP-1R Receptor,GLP1R Protein,GLP1R Receptor,GLP 1 Receptor,GLP 1R Receptor,Glucagon Like Peptide 1 Receptor,Peptide-1 Receptor, Glucagon-Like,Protein, GLP1R,Receptor, GLP-1,Receptor, GLP-1R,Receptor, GLP1R,Receptor, Glucagon-Like Peptide-1
D000077270 Exenatide A synthetic form of exendin-4, a 39-amino acid peptide isolated from the venom of the GILA MONSTER lizard (Heloderma suspectum). Exenatide increases CYCLIC AMP levels in pancreatic acinar cells and acts as a GLUCAGON-LIKE PEPTIDE-1 RECEPTOR (GLP-1) agonist and incretin mimetic, enhancing insulin secretion in response to increased glucose levels; it also suppresses inappropriate glucagon secretion and slows gastric emptying. It is used as an anti-diabetic and anti-obesity agent. AC 2993,AC 2993 LAR,Bydureon,Byetta,Ex4 Peptide,Exendin 4,Exendin-4,ITCA 650,Peptide, Ex4
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014688 Venoms Poisonous animal secretions forming fluid mixtures of many different enzymes, toxins, and other substances. These substances are produced in specialized glands and secreted through specialized delivery systems (nematocysts, spines, fangs, etc.) for disabling prey or predator. Venom

Related Publications

Susan M Clardy, and Edmund J Keliher, and James F Mohan, and Matt Sebas, and Christophe Benoist, and Diane Mathis, and Ralph Weissleder
February 2017, Endocrine,
Susan M Clardy, and Edmund J Keliher, and James F Mohan, and Matt Sebas, and Christophe Benoist, and Diane Mathis, and Ralph Weissleder
January 2021, Nuclear medicine and biology,
Susan M Clardy, and Edmund J Keliher, and James F Mohan, and Matt Sebas, and Christophe Benoist, and Diane Mathis, and Ralph Weissleder
November 2011, American journal of physiology. Endocrinology and metabolism,
Susan M Clardy, and Edmund J Keliher, and James F Mohan, and Matt Sebas, and Christophe Benoist, and Diane Mathis, and Ralph Weissleder
December 2018, The international journal of biochemistry & cell biology,
Susan M Clardy, and Edmund J Keliher, and James F Mohan, and Matt Sebas, and Christophe Benoist, and Diane Mathis, and Ralph Weissleder
December 2021, Bioorganic & medicinal chemistry,
Susan M Clardy, and Edmund J Keliher, and James F Mohan, and Matt Sebas, and Christophe Benoist, and Diane Mathis, and Ralph Weissleder
September 2022, Chembiochem : a European journal of chemical biology,
Susan M Clardy, and Edmund J Keliher, and James F Mohan, and Matt Sebas, and Christophe Benoist, and Diane Mathis, and Ralph Weissleder
December 2013, Endocrinology,
Susan M Clardy, and Edmund J Keliher, and James F Mohan, and Matt Sebas, and Christophe Benoist, and Diane Mathis, and Ralph Weissleder
August 2011, Proceedings of the National Academy of Sciences of the United States of America,
Susan M Clardy, and Edmund J Keliher, and James F Mohan, and Matt Sebas, and Christophe Benoist, and Diane Mathis, and Ralph Weissleder
January 2012, Journal of pharmacological sciences,
Susan M Clardy, and Edmund J Keliher, and James F Mohan, and Matt Sebas, and Christophe Benoist, and Diane Mathis, and Ralph Weissleder
January 2012, Journal of pharmacological sciences,
Copied contents to your clipboard!